Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Ms. Tiffany Ann Kanaga

Vice President of Global Investor Relations

Mr. Todd D. Heckman

Senior Vice President, Global Controller & Chief Accounting Officer

Mr. Matthew  D'Ambrosio

Senior Vice President and Global Chief Compliance & Ethics Officer

Ms. Lanesha T. Minnix

Executive Vice President & Global Chief Legal Officer

Ms. Ornella  Barra

Executive Vice President & Chief Operating Officer of International

Mr. Manmohan  Mahajan

Executive Vice President & Global Chief Financial Officer

Mr. Timothy C. Wentworth

Chief Executive Officer & Director

Dr. Neal Joseph Sample Ph.D.

Executive Vice President & Chief Information Officer

Ms. Elizabeth L. Burger

Executive Vice President & Chief Human Resources Officer

Mr. Stefano  Pessina

Executive Chairman of the Board

Όνομα	Κεφαλαιοποίηση αγοράς
Affimed N.V.	0M
Halozyme Therapeutics, Inc.	0M
Biogen Inc	0M
Homology Medicines, Inc.	0M
Illumina, Inc.	0M
Walgreens Boots Alliance Inc	0M
Nektar Therapeutics	0M
Transgene SA	0M
Camurus AB (publ)	0M
Relief Therapeutics Holding AG	0M
Blueprint Medicines Corporation	0M

Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc.Λίστα ανταγωνιστών

Κύριοι ανταγωνιστές